Valuation : Recordati SpA

Market Cap 10.63B 12.34B 9.99B 9.13B 17.08B 1,166B 17.14B 118B 45.85B 598B 46.35B 45.33B 1,929B P/E 2026 *
21x
P/E 2027 * 17.2x
Enterprise Value 12.4B 14.39B 11.65B 10.64B 19.92B 1,360B 19.98B 138B 53.47B 697B 54.05B 52.86B 2,249B EV / Sales 2026 *
4.44x
EV / Sales 2027 * 3.99x
Free-Float
50.46%
Yield 2026 *
2.94%
Yield 2027 * 3.24%
Manager TitleAgeSince
Chief Executive Officer 64 2021-11-30
Director of Finance/CFO 56 2025-12-31
Chief Tech/Sci/R&D Officer 56 2023-09-30
Director TitleAgeSince
Chairman 54 2021-11-30
Chairman 57 2018-06-11
Director/Board Member 53 2018-06-11
Change 5-day change 1-year change 3-year change Capi.($)
-0.88%-2.15%+54.71%+106.31% 1,024B
-1.15%+2.68%+53.97%+71.50% 663B
-1.44%+0.38%+20.40%+73.05% 453B
+0.14%-0.47%+29.49%+38.56% 352B
-1.33%+4.72%+24.69%+45.55% 304B
-1.15%+0.30%-1.49%+12.31% 252B
-1.55%+1.11%+56.10%+70.32% 236B
-0.88%+1.15%-17.09%-54.39% 206B
-0.15%+3.65%+33.90%+96.99% 187B
Average -0.93%+1.09%+28.30%+51.13% 408.71B
Weighted average by Cap. -0.96%+0.55%+36.62%+66.22%

Financials

2026 *2027 *
Net sales 2.79B 3.24B 2.62B 2.4B 4.49B 306B 4.5B 31.02B 12.04B 157B 12.17B 11.91B 507B 3.03B 3.52B 2.85B 2.6B 4.87B 332B 4.88B 33.64B 13.06B 170B 13.2B 12.91B 549B
Net income 570M 662M 536M 490M 916M 62.57B 919M 6.34B 2.46B 32.08B 2.49B 2.43B 103B 684M 794M 643M 587M 1.1B 75.07B 1.1B 7.6B 2.95B 38.49B 2.98B 2.92B 124B
Net Debt 1.77B 2.05B 1.66B 1.52B 2.84B 194B 2.85B 19.62B 7.62B 99.33B 7.7B 7.53B 320B 1.45B 1.69B 1.36B 1.25B 2.33B 159B 2.34B 16.13B 6.26B 81.67B 6.33B 6.19B 263B
Logo Recordati SpA
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (58.7%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (41.3%). Net sales are distributed geographically as follows: Italy (12.6%), Europe (53.7%), America (23.1%), Asia and Oceania (7.8%) and Africa (2.8%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-